Prospective Evaluation of Whole-Body Cancer Screening With Multiple Modalities Including [18F]Fluorodeoxyglucose Positron Emission Tomography in a Healthy Population: A Preliminary Report

• Published in: Journal of clinical oncology Vol. 27; no. 11; pp. 1767 - 1773
• Main Authors: Nishizawa, Sadahiko, Kojima, Shinsuke, Teramukai, Satoshi, Inubushi, Masayuki, Kodama, Hironobu, Maeda, Yoshiki, Okada, Hiroyuki, Zhou, Bin, Nagai, Yoji, Fukushima, Masanori
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Society of Clinical Oncology 10.04.2009
• Subjects: Adult; Aged; Biological and medical sciences; Biomarkers, Tumor - blood; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mass Screening; Medical sciences; Middle Aged; Neoplasms - blood; Neoplasms - diagnosis; Neoplasms - diagnostic imaging; Neoplasms - prevention & control; Occult Blood; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumors; Radionuclide study; Prospective; 2-deoxy-2-fluoroglucose; Cancerology; Healthy subject; Whole body; Malignant tumor; Medical screening; Positron emission tomography; Cancer; Emission tomography

To prospectively evaluate the utility of whole-body cancer screening with multiple modalities including [(18)F]fluorodeoxyglucose positron emission tomography (FDG-PET) in a healthy population. This report summarizes the results of the first three annual screenings. A total of 1,197 healthy voluntee...